Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

29.92
-1.4800-4.71%
Volume:511.88K
Turnover:15.00M
Market Cap:1.60B
PE:-15.92
High:32.29
Open:31.41
Low:28.20
Close:31.40
52wk High:32.44
52wk Low:6.42
Shares:53.37M
Float Shares:17.22M
Volume Ratio:1.56
T/O Rate:2.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8798
EPS(LYR):-1.5114
ROE:-34.75%
ROA:-23.08%
PB:5.69
PE(LYR):-19.80

Loading ...

Tyra Biosciences participates in a coferejce call with William Blair

TIPRANKS
·
1 hour ago

William Blair Initiates Tyra Bioscience at Outperform

MT Newswires Live
·
Feb 10

Analysts Offer Insights on Healthcare Companies: Tyra Bioscience (TYRA) and Novo Nordisk (NVO)

TIPRANKS
·
Feb 10

Tyra Biosciences Advances BEACH301 Dose Escalation

TIPRANKS
·
Feb 05

Tyra Bioscience (TYRA) Gets a Buy from Oppenheimer

TIPRANKS
·
Feb 03

Tyra Biosciences Is Maintained at Buy by Jefferies

Dow Jones
·
Feb 03

U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp

Reuters
·
Feb 03

Tyra Biosciences Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

Tyra Biosciences initiated with an Overweight at Barclays

TIPRANKS
·
Jan 28

Tyra Biosciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Jan 23

Tyra Biosciences price target raised to $42 from $33 at Piper Sandler

TIPRANKS
·
Jan 23

Tyra Biosciences Inc : Piper Sandler Raises Target Price to $42 From $33

THOMSON REUTERS
·
Jan 23

How Investors May Respond To Tyra Biosciences (TYRA) Strengthening Its Leadership Team And Regulatory Focus

Simply Wall St.
·
Jan 22

Tyra Biosciences Chief Discovery Officer Daniel Bensen Reports Sale of Common Shares

Reuters
·
Jan 21

Tyra Biosciences (TYRA) Is Up 9.4% After New COO Hire And 52-Week High Has The Bull Case Changed?

Simply Wall St.
·
Jan 11

Tyra Biosciences (TYRA): Assessing Valuation After New Leadership Hires and Biotechnology Index Inclusion

Simply Wall St.
·
Dec 26, 2025

Tyra Biosciences Director Robert J. More Reports Sale of Common Shares

Reuters
·
Dec 20, 2025

Tyra Biosciences Chief Discovery Officer Daniel Bensen Reports Sale of Common Shares

Reuters
·
Dec 17, 2025

Tyra Biosciences Is Maintained at Outperform by Wedbush

Dow Jones
·
Dec 16, 2025

Wedbush Raises Price Target on Tyra Bioscience to $37 From $30, Adds Stock to Best Ideas List, Keeps Outperform Rating

MT Newswires Live
·
Dec 16, 2025